Ipamorelin, a selective growth hormone secretagogue and pentapeptide, remains one of the most researched and sought-after compounds in 2026 for its potent ability to stimulate pulsatile growth hormone (GH) release from the pituitary gland without significantly affecting cortisol, prolactin, or ACTH levels. Unlike older GHRPs such as GHRP-6 or GHRP-2, ipamorelin is highly selective for […]